Published in Gene Therapy Weekly, March 1st, 2012
"We present replication-competent murine leukaemia virus (MLV) vectors, which deliver RNAi to tumor tissue upon tail vein injection. In HT1080 cells stably expressing GFP or luciferase,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2012-03-01)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.